March 23, 2023: AJOB Calls for Peer Commentaries on Ethics in Pragmatic Trials

American Journal of Bioethics cover imageThe American Journal of Bioethics (AJOB) this week issued a call for peer commentaries for a forthcoming special issue on pragmatic clinical trials. Both of the target articles for the special issue are from the NIH Pragmatic Trials Collaboratory’s Ethics & Regulatory Core.

Unlike AJOB‘s typical Open Peer Commentaries, commentaries for the special issue may be written either in response to the 2 target articles or on the topic of pragmatic trials in general. Proposals of approximately 1 paragraph are due Friday, April 7, and should be submitted via the AJOB editorial website.

After evaluating the proposals, the journal’s editorial office will contact authors to inform them of whether their proposal has been selected to be submitted as a full Open Peer Commentary. Invited commentaries will be due Wednesday, April 26. Authors are limited to a single Open Peer Commentary.

Target articles:

  • “Think Pragmatically: Investigators’ Obligations to Patient-Subjects When Research is Embedded in Care” by Stephanie Morain and Emily Largent: Growing interest in embedded research approaches—where research is incorporated into clinical care—has spurred numerous studies to generate knowledge relevant to the real-world needs of patients and other stakeholders. However, it also has presented ethical challenges. An emerging challenge is how to understand the nature and extent of investigators’ obligations to patient-subjects. Prior scholarship on investigator duties has generally been grounded upon the premise that research and clinical care are distinct activities, bearing distinct duties. Yet this premise—and its corresponding implications—are challenged when research and clinical care are deliberately integrated. After presenting three case studies from recent pragmatic clinical trials, we identify six differences between explanatory trials and embedded research that limit the application of existing scholarship for ascertaining investigator duties. We suggest that these limitations indicate a need to account for the implications of usual care and to move beyond a narrow focus on the investigator-subject dyad, one that better reflects the team- and institution-based nature of contemporary health systems.
  • “Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials?” by Andrew Garland, Stephanie Morain, and Jeremy Sugarman: Clinicians have good moral and professional reasons to contribute to pragmatic clinical trials (PCTs). We argue that clinicians have a defeasible duty to participate in this research that takes place in usual care settings and does not involve substantive deviation from their ordinary care practices. However, a variety of countervailing reasons may excuse clinicians from this duty in particular cases. Yet because there is a moral default in favor of participating, clinicians who wish to opt out of this research must justify their refusal. Reasons to refuse include that the trial is badly designed in some way, that the trial activities will violate the clinician’s conscience, or that the trial will impose excessive burdens on the clinician.

Open Peer Commentaries are typically between 500 and 1500 words and contain no more than 10 references. A guide to writing an Open Peer Commentary is available under the Resources section “Instructions and Forms” on the AJOB editorial website.

June 25, 2021: Medical Decision Making Seeks Submissions for EHR Theme Issue

Cover of the journal Medical Decision Making

Medical Decision Making, an official journal of the Society for Medical Decision Making, has extended the submission deadline in its call for papers for a special theme issue on the use of electronic health record (EHR) data in health decision research. The new submission deadline is September 30, 2021.

“EHRs remain a rich and promising longitudinal data source on patient-level characteristics with a great deal of potential, but a lot of thinking and work remains to be done to take full advantage of them to produce high-quality evidence that can advance medical care and decision making,” the journal’s announcement said.

The journal’s editors are interested in papers that advance understanding of the strengths and limitations of using EHR data in health decision research, including:

  • critical reports investigating the usefulness, benefits, and limitations of using EHRs to address specific health policy questions or inform healthcare decision making;
  • empirical papers evaluating the impact of EHR use to inform decision making around patients, clinicians, healthcare improvement programs, or health policy;
  • exploration of the challenges that arise when using EHR data for research or for patient or clinician decision support (such as bias, confounding, heterogeneity, and missing data);
  • strategies for addressing the challenges of EHR data in decision making; and
  • issues that arise in different national contexts.

Read the full call for papers.

May 13, 2019: JGIM Issues Call for Papers on Implementation Science and Quality Improvement

The Journal of General Internal Medicine (JGIM) has announced a call for papers that report findings from research at the intersection of implementation science (IS) and quality improvement (QI). Submissions are due September 3, 2019, and should focus on providing information that healthcare delivery systems need about strategies to improve patient and population outcomes. The research should involve multiple settings or systems and apply rigorous scientific methods to test the effectiveness, quality, or utility of QI/IS methods in routine care.

“These articles will illustrate how foundational knowledge and skills from QI and IS help general internal medicine clinicians, educators, and researchers achieve evidence to anchor high quality and reliable care in a learning health system environment.” — JGIM Call for Papers